SCHEMBL5947290

SCHEMBL5947290

COCC(C1CCN(C(=O)OC(C)(C)C)CC1)N1CCC(c2ccc(OC)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ HTT P42858 2/20 0.48
▸ MMP1 P03956 3/20 0.48
▸ MMP3 P08254 3/20 0.48
▸ MMP7 P09237 3/20 0.48
▸ MMP9 P14780 3/20 0.48
▸ MMP8 P22894 3/20 0.48
▸ MMP13 P45452 3/20 0.48
▸ MMP2 P08253 2/20 0.48
▸ STS P08842 1/20 0.47
▸ GPR119 Q8TDV5 3/20 0.46
▸ NAMPT P43490 1/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ CTSD P07339 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871974 0.85 ALDH1A1 (0.67) ALDH1A1HTTSTSGPR119NAMPT
SCHEMBL5458686 0.81 ALDH1A1 (0.50) ALDH1A1HTTMMP1MMP3MMP7
SCHEMBL29891542 0.81 ALDH1A1 (0.61) ALDH1A1HTTSTSGPR119NAMPT
SCHEMBL23411054 0.81 ALDH1A1 (0.61) ALDH1A1HTTSTSGPR119NAMPT
SCHEMBL5463382 0.80 ALDH1A1 (0.48) ALDH1A1HTTMMP1MMP3MMP7
SCHEMBL5414884 0.79 GPR119 (0.48) ALDH1A1HTTMMP1MMP3MMP7
SCHEMBL23060497 0.78 PDE4B (0.64) ALDH1A1HTTMMP1MMP3MMP7
SCHEMBL23411722 0.77 NAMPT (0.56) ALDH1A1HTTSTSGPR119NAMPT
SCHEMBL21714163 0.76 STS (0.56) ALDH1A1HTTMMP1MMP3MMP7
SCHEMBL22117671 0.75 GPR119 (0.56) ALDH1A1GPR119NAMPTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060069123-A1 Substituted dipiperidine CCR2 antagonists JANSSEN PHARMACEUTICA, N.V. (BE) 2006-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069123-A1 Substituted dipiperidine CCR2 antagonists CCR2, CCR1, CCR5 ALDH1A1 934/4885HTT 3317/4885MMP1 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback